Javascript must be enabled to continue!
LRRK2 microtubule sedimentation binding assay v1
View through CrossRef
Assay to determine LRRK2 protein binding to microtubules. Original assay by Andrea Dickey. Adapted by Mariusz Matyszewski for protocols.io. Assay originally used in Snead, Matyszewski, Dickey et al. 2022
Title: LRRK2 microtubule sedimentation binding assay v1
Description:
Assay to determine LRRK2 protein binding to microtubules.
Original assay by Andrea Dickey.
Adapted by Mariusz Matyszewski for protocols.
io.
Assay originally used in Snead, Matyszewski, Dickey et al.
2022.
Related Results
Membrane traffic defects in Parkinson's disease
Membrane traffic defects in Parkinson's disease
Défauts de trafic membranaire dans la maladie de Parkinson
La maladie de Parkinson (MP) est une maladie neurodégénérative progressive caractérisée par la mort de ne...
Clinical profiles and outcomes of deep brain stimulation in G2019S LRRK2 Parkinson disease
Clinical profiles and outcomes of deep brain stimulation in G2019S LRRK2 Parkinson disease
OBJECTIVE
The objective of this study was to evaluate clinical features and response to deep brain stimulation (DBS) in G2019S LRRK2-Parkinson disease (LRRK2-PD) and idiopathic PD ...
Sex differences in LRRK2 G2019S and idiopathic Parkinson's Disease
Sex differences in LRRK2 G2019S and idiopathic Parkinson's Disease
AbstractObjectiveTo evaluate sex differences and the relative effect of G2019S LRRK2 mutations in Parkinson's disease (PD).Methods530 LRRK2 PD carriers and 759 noncarrier PD (idiop...
Dundee neutrophil isolation protocol (from whole blood) v1
Dundee neutrophil isolation protocol (from whole blood) v1
We describe a fast and efficient immunomagnetic negative isolation method to purify peripheral blood neutrophils for LRRK2 kinase pathway analysis in humans Gain of kinase function...
The function of Golgi apparatus in LRRK2-associated Parkinson’s disease
The function of Golgi apparatus in LRRK2-associated Parkinson’s disease
Parkinson’s disease (PD) is a chronic neurodegenerative disease associated with the intracellular organelles. Leucine-rich repeat kinase 2 (LRRK2) is a large multi-structural domai...
Homo‐ and heterodimerization of ROCO kinases: LRRK2 kinase inhibition by the LRRK2 ROCO fragment
Homo‐ and heterodimerization of ROCO kinases: LRRK2 kinase inhibition by the LRRK2 ROCO fragment
AbstractMutations in the gene encoding leucine‐rich repeat kinase 2 (LRRK2) are the most common cause of autosomal‐dominant familial and late‐onset sporadic Parkinson’s disease (PD...
Modulation of kinesin’s load-bearing capacity by force geometry and the microtubule track
Modulation of kinesin’s load-bearing capacity by force geometry and the microtubule track
AbstractKinesin motors and their associated microtubule tracks are essential for long-distance transport of cellular cargos. Intracellular activity and proper recruitment of kinesi...
Cell autonomous role of leucine-rich repeat kinase in protection of dopaminergic neuron survival
Cell autonomous role of leucine-rich repeat kinase in protection of dopaminergic neuron survival
Abstract
Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson’s disease (PD), which is the leading neurodegenerative movement disorder c...

